Wei, Yuying <br/><br/>
Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway.  [electronic resource] 

 -  The journal of gene medicine  May 2012 
 - 353-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-2254 
<br/><br/><label>Standard No.: </label>10.1002/jgm.2624  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, Neoplasm--genetics<br/>CD8-Positive T-Lymphocytes<br/>Cancer Vaccines--administration & dosage<br/>Carcinoma, Lewis Lung--genetics<br/>Chorionic Gonadotropin, beta Subunit, Human--genetics<br/>Epitopes--genetics<br/>Female<br/>Genetic Vectors--administration & dosage<br/>HEK293 Cells<br/>Humans<br/>Immunity, Active--genetics<br/>Inhibitor of Apoptosis Proteins--genetics<br/>Lysosomal Membrane Proteins--genetics<br/>Major Histocompatibility Complex--genetics<br/>Mice<br/>Mice, Inbred C57BL<br/>Survivin<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Vaccines, DNA--administration & dosage<br/>Vascular Endothelial Growth Factor Receptor-2--genetics